DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 80 targets from JPMorgan. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from JPMorgan only. All targets JPMorgan’s record →
Its December 2027 price target of $310 is based on a valuation multiple of approximately 29 times
MercadoLibre (NASDAQ:MELI) Given New $1,850.00 Price Target at JPMorgan Chase & Co.
JPMorgan downgraded Crown Holdings (NYSE:CCK) to Neutral from Overweight and set a price target of $121.00.
the firm lowered its price target on CIFR stock to $18 from $22.
JPMorgan lowered its Apple (NASDAQ: AAPL) stock price target from $360 to $355 on Tuesday, November 3, maintaining an “Overweight” rating.
JPMorgan initiated coverage on TRex Bio (NASDAQ:TRXB) with an overweight rating and a price target of $20.00, analyst Brian Cheng announced.
META Stock Price Forecast: JPMorgan Raises Price Target to $940, Sees Over 50% Upside
JPMorgan | $37 | $36
JPMorgan initie le suivi de Palantir à surpondérer, objectif 262 dollars
JPMorgan Chase & Co. lowered their target price on Boeing from $290.00 to $240.00
boosted their target price on Coca-Cola from $95.00 to $98.00
to $31 from $33 while maintaining an Overweight rating on the shares.
JPMorgan downgraded Xylem (NYSE:XYL) to Underweight from Neutral and lowered its price target to $90.00 from $118.00.
JPMorgan: Raised from $162 to $180 (analyst table row; paraphrase)
Goldman Sachs stock: JPMorgan raises target to USD 970
JPMorgan raised its price target on 3M Co. shares to $191 from $185 while maintaining an Overweight rating.
JPMorgan lowered its price target on Corning stock (NYSE:GLW) to $165 from $170 while maintaining a Neutral rating.
lowered its price target on GE Aerospace stock (NYSE:GE) to $375 from $400.
with a Neutral rating and set a price target of $485
with an overweight rating and set a price target of $167.00
JPMorgan upgraded Intel (NASDAQ:INTC) from Underweight to Neutral with a price target of $85.00.
Last week, JPMorgan raised its price target on DIS shares to $140 from $139 and maintained an ‘Overweight’ rating.
Fundamentally and relative to Energy and Fossil Fuels benchmarks, Diamondback offers superior free cash flow yield and capital efficiency, now validated by multiple bullish target hikes (JPM $253, Street average ~$236–238) and Scotiabank’s Outperform at $250.
to $283 from $287 while maintaining an Overweight rating on the stock
JPMorgan initiated coverage on MGE Energy Inc. (NASDAQ:MGEE) with a Neutral rating and set a price target of $76.00.
JPMorgan reiterated an Overweight rating and $48.00 price target on Tango Therapeutics Inc. (NASDAQ:TNGX).
JPMorgan upgraded CRH to Overweight from Not Rated and set a December 2027 price target of $115
JPMorgan downgraded Allient Inc. (NASDAQ:ALNT) to Neutral from Overweight and maintained its price target of $120.00.
JPMorgan analyst Samik Chatterjee raised the price target on Apple stock to $360 from $340 and kept an Overweight rating.
JPMorgan downgraded Enact Holdings Inc (NASDAQ:ACT) to Underweight from Neutral and lowered its price target to $44.00
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer today and set a price target of $30.00.
JPMorgan Chase & Co. decreased their target price on PepsiCo from $138.00 to $137.00 and set a "neutral" rating for the company in a research report on Friday.
JPMorgan initiated coverage of Neurogene with an Overweight rating and set a price target of $60.00.
JPMorgan downgraded Leidos Holdings (NYSE:LDOS) to Neutral from Overweight and cut its price target to $142 from $160.
JPMorgan upgraded Afya Ltd. (NASDAQ:AFYA) to Overweight from Neutral on Wednesday, while lowering its price target to $19.00 from $21.00.
JPMorgan upgraded RXO, Inc. (NYSE:RXO) from Underweight to Neutral and raised its price target to $30.00 from $22.00 following the company's acquisition announcement.
JPMorgan upgraded Corteva Inc. (NYSE:CTVA) from Neutral to Overweight with a price target of $19.00, down from $83.00, following the company's separation of its seed business.
J.P. Morgan reduced its price target to $33 from $40 while maintaining its "Underweight" rating.
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Bump from JPMorgan Chase & Co.
On October 1, 2026, JP Morgan maintained a Neutral rating on Wells Fargo WFC, while lowering the price target from $95.50 to $91.50.
JPMorgan Chase & Co. lowered their price objective on Bank of America from $68.00 to $62.00 and set an "overweight" rating on the stock in a research report on Friday.
Similarly, JPMorgan moved its price target from $820 to $920 following Meta Connect, citing the progress of Muse and Meta's broader AI efforts.
Specifically, analyst Doug Anmuth reiterated his ‘Overweight’ – ‘Buy’ – rating for Alphabet shares in an October 1 note and set his price target at $420, meaning, in his estimate, GOOGL equity is set for a 24.17% rally from $338.24 at the latest close.
set a price target of $120.00
JPMorgan has initiated coverage of Kura Oncology (NASDAQ: KURA) with an "overweight" rating and established a price target of $30.00
The target implies 64% upside from the current price of $45.84
JPMorgan kept its Overweight rating and $1,540 price target on Micron
Tesla shares fell 1.3% after JPMorgan cut its price target from $445 to $415 while maintaining a Neutral rating.
PepsiCo (NASDAQ:PEP) Downgraded by JPMorgan Chase & Co. to Neutral
JPMorgan Chase & Co. reduced their target price on shares of CocaCola from $96.00 to $95.00 and set an 'overweight' rating for the company
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.